
Ocrelizumab is indicated for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease, in adults.
Ocrelizumab is indicated for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease, in adults.
The results showed that one 300 mg dose of AZD7442 reduced the risk of developing symptomatic COVID-19 by 83% and one 600 mg dose reduced the risk of developing severe COVID-19 or death (from any cause) by 88% compared to the placebo.
The FDA has approved maribavir for the treatment of adults and pediatric patients aged 12 years or older and weighing at least 35 kg with post-transplant cytomegalovirus infection/disease that is refractory to treatment with ganciclovir, valganciclovir, cidofovir, or foscarnet.
Are you curious about what other pharmacists earn? About the job satisfaction and compensation of pharmacists in other geographic areas? So are we!
Mobocertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that irreversibly binds to and inhibits EGFR exon 20 insertion mutations at lower concentrations than wild type (WT) EGFR.
The new sFIS assay may be capable of identifying immune biomarkers indicative of survival chances and treatment effectiveness for patients with ovarian cancer.
The researchers based this conclusion on the analysis of VZV-infected primary human brain vascular adventitial fibroblasts (HBVAFs), which are among the first arterial cells infected in VZV vasculopathy.
The primary goal for 2021 is for patients to become aware of their diabetes status and complete smaller healthy lifestyle changes to make a big difference in diabetes prevention and management.
Among participants who had been infected with SARS-CoV-2, heart rate was reduced during physical exertion, and recovery was delayed after the exertion.
Patients with advanced renal cell carcinoma who were given the combination of nivolumab and ipilimumab demonstrated a significantly longer overall survival than those who received sunitinib.
Rituximab-pvvr is indicated for the treatment of adult patients with non-Hodgkin lymphoma, chronic lymphocytic leukemia, and granulomatosis.
The analysis found that vaccination rates increased from 36% to 60% between January 2021 and April 2021 but then slowed, reaching just 70% as of September 2021.
Under the agreement, the government would acquire 10 million treatment courses to be delivered by Pfizer beginning later this year and concluding in 2022.
Rita Wise, DEd, MSN, RN, program director of the Masters in Nursing Education and Nursing Administration programs at Pennsylvania College of Health Sciences, discusses her hopes for how the country and health systems will respond to the national nurse staffing crisis.
Investigators have developed an immunotherapy that is a potential option for children with hard-to-treat brain cancer.
Vericiguat is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure.
mRNA encoding vascular endothelial growth factor into the myocardium of patients undergoing elective coronary artery bypass surgery was both safe and tolerable in patients with heart failure.
Ten quiz questions to assess your knowledge on common symptoms and treatments for HIV.
Iptacopan demonstrated statistically significant and clinically important reductions in proteinuria for patients with C3 glomerulopathy.
Juluca is indicated as a complete regimen for the treatment of HIV-1 infection in adults.
Investigators used mouse models and found that the stress hormone suppressed the innate immune system that normally protects the gut from bacteria that is associated with the condition.
The CDC Advisory Committee on Immunization Practices voted to recommend the use of a booster dose of the Moderna COVID-19 vaccine.
The Pfizer COVID-19 vaccine booster dose is the same strength as the primary series of the Pfizer COVID-19 vaccine, with findings demonstrating the same level of safety as the primary series.
The smartphone group were nearly 4 times more likely to have their wound infection diagnosed within 7 days of their surgery compared to the routine care group.
Individuals with diabetes and atrial fibrillation were less likely to notice symptoms of irregular heartbeat.
The difference in COVID-19 infection time between patients receiving heparin and those who did not was approximately 4 days on average.
Those with attention-deficit/hyperactivity disorder are much more likely to have GAD at some point in their lives than others who do not have it.
RSV causes an estimated 14,000 deaths and 177,000 hospitalizations annually among US adults over 65 years of age.
Breast cancer found to be the most expensive type of the disease, costing approximately $3.4 billion in the United States.